Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2008.109744v1, 2008; 10.1373/clinchem.2008.109744
This Article
Right arrow Full Text (PDF)
Right arrow HTML Page - index.htslp
Right arrow All Versions of this Article:
clinchem.2008.109744v1
54/12/2055    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, M. H.
Right arrow Articles by Silverman, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, M. H.
Right arrow Articles by Silverman, E. K.

Received on ,
Accepted on ,

Brief Communications

High-Resolution Melting Curve Analysis of Genomic and Whole-Genome Amplified DNA

Michael H. Cho 1*, Dawn Ciulla 2, Barbara J. Klanderman 3, Benjamin A. Raby 1, Edwin K. Silverman 1

1 Channing Laboratory, Brigham and Women's Hospital, Boston, MA, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, and Harvard Medical School, Boston, MA
2 Channing Laboratory, Brigham and Women's Hospital, Boston, MA
3 Channing Laboratory, Brigham and Women's Hospital, Boston, MA, and Harvard Medical School, Boston, MA

* To whom correspondence should be addressed. E-mail: michael.cho{at}channing.harvard.edu.

BACKGROUND: High-resolution melting curve analysis is an accurate method for mutation detection in genomic DNA. However, performance in whole-genome amplified (WGA) vs genomic DNA has not been directly compared.

METHODS: In 39 paired genomic and WGA samples, 23 amplicons from 9 genes were PCR amplified and analyzed by high-resolution melting curve analysis using the 96-well LightScanner (Idaho Technology). We used genotyping and bidirectional resequencing to verify melting curve results.

RESULTS: Melting patterns were concordant between the genomic and WGA samples in 823 of 863 (95%) analyzed sample pairs. Of the discordant patterns, there was an overrepresentation of alternate melting curve patterns in the WGA samples, suggesting the presence of a mutation (false positives). Targeted resequencing in 135 genomic and 136 WGA samples revealed 43 single nucleotide polymorphisms (SNPs). All SNPs detected in genomic samples were also detected in WGA. Additional genotyping and sequencing allowed the classification of 628 genomic and 614 WGA amplicon samples. Heterozygous variants were identified by non–wild-type melting pattern in 98% of genomic and 97% of WGA samples (P = 0.11). Wild types were correctly classified in 99% of genomic and 91% of WGA samples (P < 0.001).

CONCLUSIONS: In WGA DNA, high-resolution DNA melting curve analysis is a sensitive tool for SNP discovery through detection of heterozygote variants; however, it may misclassify a greater number of wild-type samples.




The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. H. Cho, D. M. Ciulla, B. J. Klanderman, C. P. Hersh, A. A. Litonjua, D. Sparrow, B. A. Raby, and E. K. Silverman
Analysis of Exonic Elastin Variants in Severe, Early-Onset Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol., June 1, 2009; 40(6): 751 - 755.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.